Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review

por Kendler, David L., Cosman, Felicia, Stad, Robert Kees, Ferrari, Serge
Publicado 2021

Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study

por Spangler, Leslie, Nielson, Carrie M., Brookhart, M. Alan, Hernandez, Rohini K., Stad, Robert Kees, Lin, Tzu‐Chieh
Publicado 2023

Bone Mineral Density After Transitioning From Denosumab to Alendronate

por Kendler, David, Chines, Arkadi, Clark, Patricia, Ebeling, Peter R, McClung, Michael, Rhee, Yumie, Huang, Shuang, Stad, Robert Kees
Publicado 2019

Prevalence of FRAX risk factors and the osteoporosis treatment gap among women ≥ 70 years of age in routine primary care across 8 countries in Europe

por McCloskey, Eugene, Rathi, Jeetandera, Heijmans, Stephane, Blagden, Mark, Cortet, Bernard, Czerwinski, Edward, Hadji, Peyman, Payer, Juraj, Palmer, Kerry, Stad, Robert, O’Kelly, James, Papapoulos, Socrates
Publicado 2022

The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids

por Saag, Kenneth G., McDermott, Michele T., Adachi, Jonathan, Lems, Willem, Lane, Nancy E., Geusens, Piet, Stad, Robert Kees, Chen, Li, Huang, Shuang, Dore, Robin, Cohen, Stanley
Publicado 2022